344 related articles for article (PubMed ID: 34779868)
1. COVID-19 vaccination in autoimmune disease (COVAD) survey protocol.
Sen P; Gupta L; Lilleker JB; Aggarwal V; Kardes S; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; O'Callaghan AS; Nikiphorou E; Tan AL; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Cagnotto G; Nune A; Distler O; Chinoy H; Aggarwal V; Aggarwal R;
Rheumatol Int; 2022 Jan; 42(1):23-29. PubMed ID: 34779868
[TBL] [Abstract][Full Text] [Related]
2. Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys.
Sen P; R N; Houshmand N; Moghadam Kia S; Joshi M; Saha S; Jagtap K; Agarwal V; Nune A; Nikiphorou E; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Makol A; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; García-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Akawatcharangura Goo P; Shumnalieva R; Chen YM; Hoff LS; El Kibbi L; Halabi H; Vaidya B; Sazliyana Shaharir S; Hasan ATMT; Dey D; Gutiérrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; Day J; Chinoy H; ; Agarwal V; Aggarwal R; Gupta L
Rheumatology (Oxford); 2023 Oct; 62(10):3291-3301. PubMed ID: 36734536
[TBL] [Abstract][Full Text] [Related]
3. COVAD survey 2 long-term outcomes: unmet need and protocol.
Fazal ZZ; Sen P; Joshi M; Ravichandran N; Lilleker JB; Agarwal V; Kardes S; Kim M; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Tan AL; Chatterjee T; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Selva-O'Callaghan A; Nune A; Knitza J; Kuwana M; Gutiérrez CT; Caballero-Uribe CV; Dey D; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Rheumatol Int; 2022 Dec; 42(12):2151-2158. PubMed ID: 35964271
[TBL] [Abstract][Full Text] [Related]
4. Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys.
Jagtap K; Naveen R; Day J; Sen P; Vaidya B; Nune A; Nikiphorou E; Tan AL; Agarwal V; Saha S; Shinjo SK; Ziade N; Joshi M; Velikova T; Milchert M; Parodis I; Edgar Gracia-Ramos A; Cavagna L; Kuwana M; Knitza J; Makol A; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; García-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Goo PA; Shumnalieva R; Chen YM; Hoff LS; El Kibbi L; Halabi H; Sazliyana Shaharir S; Hasan ATMT; Dey D; Gutiérrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Saavedra MA; Distler O; ; Chinoy H; Agarwal V; Aggarwal R; Gupta L
Rheumatology (Oxford); 2023 Dec; 62(12):3838-3848. PubMed ID: 36961331
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study.
Doskaliuk B; Ravichandran N; Sen P; Day J; Joshi M; Nune A; Nikiphorou E; Saha S; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Jagtap K; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Chen YM; Makol A; Agarwal V; Patel A; Pauling JD; Wincup C; Barman B; Tehozol EAZ; Serrano JR; La Torre IG; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Goo PA; Shumnalieva R; Hoff LS; Kibbi LE; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Gutiérrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; ; Chinoy H; Agarwal V; Aggarwal R; Gupta L
Rheumatol Int; 2023 Sep; 43(9):1651-1664. PubMed ID: 37351634
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study.
Andreoli L; Lini D; Schreiber K; Parodis I; Sen P; Ravichandran N; Day J; Joshi M; Jagtap K; Nune A; Nikiphorou E; Agarwal V; Saha S; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Makol A; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Serrano JR; De La Torre IG; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Akarawatcharangura Goo P; Shumnalieva R; Chen YM; Hoff LS; El Kibbi L; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Toro Gutiérrez CE; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Saavedra MA; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Rheumatology (Oxford); 2024 May; 63(5):1341-1351. PubMed ID: 37505460
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey.
Hoff LS; Ravichandran N; Shinjo SK; Day J; Sen P; Junior JG; Lilleker JB; Joshi M; Agarwal V; Kardes S; Kim M; Milchert M; Makol A; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; O'Callaghan AS; Nikiphorou E; Tan AL; Chatterjee T; Cavagna L; Saavedra MA; Ziade N; Knitza J; Kuwana M; Nune A; Distler O; Cansu DÜ; Traboco L; Wibowo SAK; Tehozol EAZ; Serrano JR; La Torre IG; Wincup C; Pauling JD; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Rheumatol Int; 2023 Jan; 43(1):47-58. PubMed ID: 36271958
[TBL] [Abstract][Full Text] [Related]
8. Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey.
Naveen R; Thakare DR; Kuwana M; Pauling JD; Day J; Joshi M; Parodis I; Sen P; Jagtap K; Nikiphorou E; Saha S; Agarwal V; Chatterjee T; Lilleker JB; Kardes S; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Tan AL; Nune A; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Distler O; Chinoy H; ; Aggarwal R; Gupta L; Agarwal V; Makol A
Rheumatol Int; 2023 Jul; 43(7):1265-1275. PubMed ID: 37000295
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study.
Sen P; Ravichandran N; Nune A; Lilleker JB; Agarwal V; Kardes S; Kim M; Day J; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Selva O'Callaghan A; Nikiphorou E; Chatterjee T; Tan AL; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Rheumatology (Oxford); 2022 Dec; 62(1):65-76. PubMed ID: 35713499
[TBL] [Abstract][Full Text] [Related]
10. Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys.
R N; Sen P; Griger Z; Day J; Joshi M; Nune A; Nikiphorou E; Saha S; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Jagtap K; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Chen YM; Makol A; Agarwal V; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; García-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Akarawatcharangura Goo P; Shumnalieva R; Hoff LS; El Kibbi L; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Toro Gutiérrez CE; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Rheumatology (Oxford); 2024 Jan; 63(1):127-139. PubMed ID: 37084267
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies.
Gil-Vila A; Ravichandran N; Selva-O'Callaghan A; Sen P; Nune A; Gaur PS; Gonzalez RA; Lilleker JB; Joshi M; Agarwal V; Kardes S; Kim M; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Tan AL; Chatterjee T; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Muscle Nerve; 2022 Oct; 66(4):426-437. PubMed ID: 35869701
[TBL] [Abstract][Full Text] [Related]
12. Covid-19 vaccination in autoimmune rheumatic diseases: A multi-center survey from southern India.
Mohanasundaram K; Santhanam S; Natarajan R; Murugesan H; Nambi T; Chilikuri B; Nallasivan S
Int J Rheum Dis; 2022 Sep; 25(9):1046-1052. PubMed ID: 35773944
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study.
Fragoulis GE; Bournia VK; Mavrea E; Evangelatos G; Fragiadaki K; Karamanakos A; Kravariti E; Laskari K; Panopoulos S; Pappa M; Mitsikostas DD; Tektonidou MG; Vassilopoulos D; Sfikakis PP
Rheumatol Int; 2022 Jan; 42(1):31-39. PubMed ID: 34739573
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group.
Shumnalieva R; Ravichandran N; Hannah J; Javaid M; Darooka N; Roy D; Gonzalez DE; Velikova T; Milchert M; Kuwana M; Joshi M; Gracia-Ramos AE; Boyd P; Yaadav P; Cheng K; Kobert L; Cavagna L; Sen P; Day J; Makol A; Gutiérrez CET; Caballero-Uribe CV; Saha S; Parodis I; Dey D; Nikiphorou E; Distler O; Kadam E; Tan AL; Shinjo SK; Ziade N; Knitza J; Chinoy H; Aggarwal R; Agarwal V; Gupta L;
Int J Rheum Dis; 2024 May; 27(5):e15178. PubMed ID: 38742751
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Vaccination Intention and Vaccine Hesitancy among Patients with Autoimmune and Autoinflammatory Rheumatological Diseases: A Survey.
Tharwat S; Abdelsalam HA; Abdelsalam A; Nassar MK
Int J Clin Pract; 2022; 2022():5931506. PubMed ID: 35685586
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis.
Naveen R; Parodis I; Joshi M; Sen P; Lindblom J; Agarwal V; Lilleker JB; Tan AL; Nune A; Shinjo SK; Salim B; Ziade N; Velikova T; Edgar Gracia-Ramos A; Saavedra MA; Day J; Makol A; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L; Nikiphorou E;
Rheumatology (Oxford); 2023 Jul; 62(7):2366-2376. PubMed ID: 36315075
[TBL] [Abstract][Full Text] [Related]
17. Prior COVID-19 infection: an underappreciated factor in vaccine hesitancy in the USA.
Do DP; Frank R
J Public Health (Oxf); 2022 Jun; 44(2):471-474. PubMed ID: 35020935
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey.
Tsai R; Hervey J; Hoffman K; Wood J; Johnson J; Deighton D; Clermont D; Loew B; Goldberg SL
JMIR Public Health Surveill; 2022 Jan; 8(1):e29872. PubMed ID: 34709184
[TBL] [Abstract][Full Text] [Related]
19. Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study.
Santos CS; Chen JP; Nikiphorou E; Tseng CW; Gutiérrez CET; Tan AL; Nune A; Kadam E; Kuwana M; Day J; Saha S; Velikova T; Lilleker JB; Caballero-Uribe CV; Sen P; Chinoy H; Aggarwal R; Agarwal V; Gupta L; Chen YM;
Rheumatol Int; 2024 May; 44(5):805-817. PubMed ID: 38470502
[TBL] [Abstract][Full Text] [Related]
20. Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort.
Panchawagh S; Bohdana D; Kuwana M; Yoshida A; Yomono K; Pauling JD; Makol A; Kadam E; Day J; Chatterjee T; Katchamart W; Goo PA; Nikiphorou E; Sen P; Dey D; Cavagna L; Gutiérrez CET; Agarwal V; Milchert M; Ziade N; Distler O; Group CS; Chinoy H; Aggarwal R; Gupta L; Agarwal V
Rheumatol Int; 2023 Dec; 43(12):2211-2220. PubMed ID: 37712977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
